Immunotherapy is real, evidence-based cancer medicine that works by helping your own immune system recognize and attack certain tumors, and it is offered at several MTA-verified cancer centers abroad, though it is approved only for specific cancers and situations and is never a universal cure. If you want to compare accredited options, you can browse verified providers here.
This article explains, in plain terms, what approved immunotherapy actually is, who may be a candidate, how testing and biomarkers guide the decision, the honest benefits and the distinctive immune-related side effects, and what costs tend to look like across borders. It is written to inform, not to promise. Whether immunotherapy is right for you, and which type, is a clinical decision made by your treating oncologist. We also draw a clear line between genuine, regulator-approved immunotherapy and the unproven "immune boosting" treatments that some clinics market as cancer cures.
What Approved Immunotherapy Actually Is
Immunotherapy is a category of cancer treatment that acts on the immune system rather than attacking tumor cells directly the way traditional chemotherapy does. Over the past decade, several forms have earned regulatory approval after rigorous clinical trials, and they are now standard options for particular cancers. They are powerful tools for the right patient, but they are not interchangeable and not effective against every tumor type.
The main approved categories include:
- Checkpoint inhibitors: drugs that release the natural "brakes" on immune cells so they can better recognize cancer. These are used in certain melanomas, lung cancers, kidney cancers, bladder cancers, and others, often depending on specific test results.
- CAR-T cell therapy: a patient's own T cells are collected, engineered in a laboratory, and returned to target the cancer. It is approved for some blood cancers, such as certain lymphomas and leukemias, and is a highly specialized, intensive treatment.
- Monoclonal antibodies and related targeted immune therapies: laboratory-made antibodies that flag cancer cells or deliver treatment to them, used across a range of approved indications.
- Cancer treatment vaccines and cytokine therapies: approved for a limited set of cancers and specific clinical situations.
The key point is that each has a defined, approved use. An oncologist matches the therapy to the diagnosis, the stage, and the biology of the individual tumor, not the other way around.
Who May Be a Candidate, and How Testing Guides It
Candidacy for immunotherapy is decided case by case, and biomarker testing is central to that decision. For many checkpoint inhibitors, pathologists examine the tumor for markers that predict whether the immune approach is likely to help. Common examples include PD-L1 expression levels, microsatellite instability or mismatch repair status, and tumor mutational burden. These are not abstract details: they often determine whether a given drug is appropriate at all.
Beyond the tumor's biology, oncologists weigh the cancer type and stage, prior treatments, organ function, and any pre-existing autoimmune or inflammatory conditions, because immunotherapy can worsen some of those. A treatment that is standard and highly effective for one patient may be unsuitable or even risky for another with a different tumor profile. This is why a complete, current pathology report and the records from your home oncology team matter so much when you seek care abroad.
Honest Benefits and Realistic Expectations
For some patients, approved immunotherapy has changed what is possible, producing durable responses in cancers that were once very difficult to treat. At the same time, responses vary widely. Many patients do not respond, some respond for a time and then progress, and immunotherapy is frequently used alongside surgery, radiation, or chemotherapy rather than on its own.
No ethical center can promise a cure or a specific survival outcome, and you should be cautious of any provider that does. A good oncology team will talk with you honestly about the probability of benefit for your specific situation, the goals of treatment, and what success would and would not look like. Gathering that information carefully is part of making a sound decision.
The Distinctive Side Effects You Should Know
Because immunotherapy activates the immune system, its side effects differ from those of chemotherapy. The immune system can begin attacking healthy tissue, causing immune-related reactions that can affect almost any organ. These range from mild to serious and need prompt attention.
- Skin reactions such as rash or itching.
- Inflammation of the colon causing diarrhea, or inflammation of the lungs, liver, or hormone-producing glands.
- Fatigue, joint pain, and flu-like symptoms.
- Less commonly, more serious effects on the heart, kidneys, nervous system, or endocrine organs.
Many immune-related side effects are manageable when caught early, often with careful monitoring and, if needed, medications that calm the immune response. This is one reason continuity of care matters: you need a plan for recognizing and treating side effects both during treatment abroad and after you return home, coordinated with your local physicians.
A Clear Warning: Approved Therapy Versus Unproven "Immune Boosting"
This distinction can protect your health and your finances. Some clinics, in various countries, market "alternative immunotherapy," "immune-boosting" infusions, or similar treatments as cancer cures. These are generally not supported by credible clinical evidence, are not the same as the regulator-approved immunotherapies described above, and can be both expensive and harmful, especially if they delay effective treatment.
Genuine immunotherapy is approved by recognized authorities for defined indications, delivered in accredited hospitals, prescribed by qualified oncologists, and backed by published trial data. If a provider promises a cure, pressures you to decide quickly, cannot explain the evidence for your specific cancer, or offers a vague "immune therapy" that is not a recognized approved treatment, treat that as a serious warning sign and discuss it with your own oncologist.
Realistic Costs in Plain Terms
Immunotherapy is among the more costly cancer treatments, and the total depends heavily on the drug, the number of cycles, and the length of treatment, which can run for many months. Costs are best thought of in ranges. A single course can reach well into the tens of thousands of US dollars, and ongoing treatment can be considerably more. Highly specialized options such as CAR-T are more expensive still.
Seeking care abroad can reduce certain costs relative to some high-cost home markets, but savings vary and should never be the only factor for a cancer decision. When you request a package quote, confirm in writing what is and is not included. A quote may cover consultations, the drug and its administration, and some monitoring, while often excluding full diagnostic workups, management of complications, extended hospital stays, repeat cycles, travel, accommodation, and follow-up care after you return home.
MTA-Verified Cancer Centers Offering Immunotherapy
The following providers are verified on Better by MTA and offer oncology services with international patient support. Availability of specific immunotherapies depends on your diagnosis and the center's current programs, so confirm details directly.
Apollo Hospitals Enterprise Limited - MTA Verified
Chennai, India
- Location: Chennai, India.
- Focus: A major oncology destination with comprehensive cancer services and a large international patient program.
- Languages: English and regional languages.
- International services: Support for overseas patients, including help with records review, scheduling, and logistics.
Best for: patients seeking an established, high-volume oncology center in Asia.
View Apollo Hospitals Enterprise Limited on Better by MTA
Bumrungrad International Hospital - MTA Verified
Bangkok, Thailand
- Location: Bangkok, Thailand.
- Focus: A JCI-accredited international hospital with oncology services and extensive experience treating patients from abroad.
- Languages: English and Thai.
- International services: Dedicated international patient services covering coordination, interpretation, and travel support.
Best for: patients who want an internationally accredited hospital with strong cross-border patient infrastructure.
View Bumrungrad International Hospital on Better by MTA
Humanitas Research Hospital - MTA Verified
Rozzano, Milan, Italy
- Location: Rozzano, Milan, Italy.
- Focus: An academic cancer center combining clinical oncology with research.
- Languages: English and Italian.
- International services: International patient coordination for consultations and treatment planning.
Best for: patients seeking an academic, research-connected European cancer center.
View Humanitas Research Hospital on Better by MTA
King Faisal Specialist Hospital & Research Centre - MTA Verified
Riyadh, Saudi Arabia
- Location: Riyadh, Saudi Arabia.
- Focus: A leading specialist research hospital with advanced oncology services.
- Languages: English and Arabic.
- International services: International patient support for referrals, records, and care coordination.
Best for: patients looking for an advanced specialist and research hospital in the region.
View King Faisal Specialist Hospital & Research Centre on Better by MTA
King's College Hospital Dubai - MTA Verified
Dubai, United Arab Emirates
- Location: Dubai, United Arab Emirates.
- Focus: A UK-affiliated hospital offering oncology services.
- Languages: English and Arabic.
- International services: International patient support with coordination for overseas patients.
Best for: patients who value a UK-affiliated hospital in a central, well-connected location.
View King's College Hospital Dubai on Better by MTA
Burjeel Medical City - MTA Verified
Abu Dhabi, United Arab Emirates
- Location: Abu Dhabi, United Arab Emirates.
- Focus: A quaternary hospital with comprehensive oncology services.
- Languages: English and Arabic.
- International services: International patient coordination and support services.
Best for: patients seeking a comprehensive, high-complexity oncology center in the UAE.
View Burjeel Medical City on Better by MTA
How to Choose a Center for Immunotherapy
Choosing where to receive cancer treatment is one of the most important decisions you will make, and it deserves careful, unhurried comparison. Use these points as a starting framework and bring them to your own oncologist.
- Confirm accreditation and the center's specific experience with your cancer type and the immunotherapy being proposed.
- Ask whether the recommended therapy is a recognized, approved treatment for your diagnosis, and request the biomarker testing that supports it.
- Clarify how immune-related side effects will be monitored and treated, both during care and after you return home.
- Get written detail on what a package covers, how ongoing cycles are billed, and what is excluded.
- Insist on clear, evidence-based answers and be wary of any cure promises or vague "immune-boosting" offers, and when you are ready to compare options side by side, get a free quote through Better by MTA.
Ready to Explore Immunotherapy Options Abroad?
Take the time to gather solid information, share every option and quote with your own treating oncologist, and keep your expectations grounded in what the evidence supports for your specific cancer. Immunotherapy can be a meaningful part of modern cancer care for the right patient, but the right path is the one decided with your medical team, not a promise made by a clinic. Use verified providers, ask hard questions, and move forward only when you feel genuinely informed.
Better by MTA helps you compare verified providers, request quotes, and coordinate care with confidence, powered by Mastercard payment infrastructure and compliant with HIPAA, GDPR, and SOC 2 standards, so your information and payments are handled securely from first inquiry to follow-up.
By Jonathan Edelheit, CEO and Co-Founder, Medical Tourism Association. Last updated October 2026.
.png)
